Results of a Phase 1b study to confirm safety and tolerability of olesoxime in multiple sclerosis patients - Archive ouverte HAL Access content directly
Conference Papers Year : 2015

Results of a Phase 1b study to confirm safety and tolerability of olesoxime in multiple sclerosis patients

(1) , (2) , (3, 4) , (5, 6) , (7) , (8) , (9) , (2) , (1) , (1) , (2) , (2) , (2) , (3) , (3) , (3) , (10) , (11) , (7) , (5) , (7) , (8) , (8) , (8) , (8)
1
2
3
4
5
6
7
8
9
10
11
Sophie Le Lamer
  • Function : Author
  • PersonId : 952774
Adil Maarouf
Christophe Portefaix
Laurent Pierot
  • Function : Author
  • PersonId : 931409
Valerie Cuvier
  • Function : Author
Julien Veys
  • Function : Author
Rebecca Pruss
  • Function : Author
Wilfried Hauke
  • Function : Author
Not file

Dates and versions

inserm-01244547 , version 1 (15-12-2015)

Identifiers

  • HAL Id : inserm-01244547 , version 1

Cite

Jean Pelletier, Jean-Philippe Ranjeva, Ayman Tourbah, Gilles Edan, Christian Barillot, et al.. Results of a Phase 1b study to confirm safety and tolerability of olesoxime in multiple sclerosis patients. American Academy of Neurology, Apr 2015, Washington, DC, United States. ⟨inserm-01244547⟩
338 View
0 Download

Share

Gmail Facebook Twitter LinkedIn More